Skip to main content
. 2010 Jan;3(1):11–22. doi: 10.1177/1756283X09352095

Box 7. Summary of IV PPI and adverse events.

• IV PPI has been associated with the development of nosocomial pneumonia in critically ill patients.
• PPI has also been linked to the development of SBP in cirrhotics.
• IV PPI in these patients should be used judiciously, and their indications frequently reviewed, as PPI is therapy is often inappropriately continued.

IV, intravenous; PPIs, proton-pump inhibitors; SBP, spontaneous bacterial peritonitis